BTEC is a collaborative program among Carnegie Mellon's School of Engineering, Mellon College of Sciences, and Robotics Institute, with the University of Pittsburgh Medical Center, the University of Pittsburgh, Children's Hospital and Duquesne University.

Our mission is to develop technologies that will translate into safe and effective clinical therapies. The bone and cartilage clinical therapies will treat developmental deformities, ablative injuries, degenerative changes, tendon and ligament healing, hypoplastic fat, and vascular insufficiencies. The center encourages the transfer of developed technologies and treatments to enable new biotechnology ventures providing jobs and a regional economic development.

The BTEC environment is rich in resources and personnel that provides for academic and professional development. This environment enables intellectual stimulus, and interactions among experienced professionals, post-docs, clinicians, fellows, undergraduates, graduates, and visiting scholars.

BTEC's research program is comprehensive, blending the diverse background and talents of molecular cell biologists, polymer chemists, clinicians and engineers. The research focuses on understanding the molecular basis for bone formation and wound healing, and applying this knowledge to engineer tissues using therapeutic systems of biomaterials, cells and signaling molecules.